Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05314517 |
|---|---|
| Brief Title: | A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis (RESOLVE-Lung) |
| First Submitted : | March 30, 2022 |
| First Submitted that Met QC Criteria : | March 30, 2022 |
| First Posted : | April 6, 2022 |
| Last Update Submitted that Met QC Criteria : | April 26, 2024 |
| Last Update Posted : | April 30, 2024 |